(原标题：利欧股份（002131）：机械制造与数字营销双轮驱动2025上半年预计盈利3.5—4.5亿元) 此外，今年1月1日，公司提出建议并作为编写小组长单位主导起草的《互联网广告基于生成式人工智能 的创意素材元数据管理指南》双团体技术标准，已于2025年1月1日正式实施。作为我国首个AIGC技术 在广告创意素材管理领域的推荐标准，该标准填补了AI营销领域的技术标准化空白，标志着中国数字 广告产业迈入标准化、规范化、智能化发展的新阶段，彰显了公司在AI营销领域的优势布局与领导地 位。 展望未来，利欧股份将继续坚持创新驱动，深化业务布局，持续提升核心竞争力。(CIS) 与此同时，数字营销业务板块表现同样亮眼。2025年上半年，公司持续优化客户结构，进一步加强信用 控制体系建设，盈利能力和现金流水平均有明显提升。 值得注意的是，进入2025年以来，利欧数字营销在AI营销领域持续突破。2025年1月，利欧数字发布新 战略——以AI为核心驱动力，为客户提供品效销一体的全链路服务，全面提升运营效率，成为中国最 具商业价值的数字营销集团。近日，利欧数字旗下微创时代凭借在AIGC创意应用与投放策略上的卓越 表现，获得快手磁 ...

7月14日晚间，蓝帆医疗（002382）（002382.SZ）披露半年度业绩预告，2025年上半年公司归母净利润 预计减亏6.38%至37.58%，亏损收窄至1.5亿元至1亿元。值得关注的是，公司指出，得益于公司新产品 持续放量，心脑血管事业部2025年半年度实现销售收入超过6.9亿元，同比增长超过20%，销售费用 率、管理费用率进一步下降，经营层面不仅实现扭亏，而且贡献了显著利润。 对于二季度业绩波动的原因，公告指出，一方面，公司参股投资的苏州同心医疗科技股份有限公司于 2025年6月底完成上市前融资，其一级市场估值变动造成公司其他非流动金融资产确认公允价值变动损 失约1.2亿元，但不涉及现金流出；另一方面，因2024年子公司蓝帆柏盛引入10亿元战略投资相关事 宜，导致2025年第二季度计提财务费用2500万元，影响了公司利润表现，该事项也不涉及现金流出。 从公司所提原因来看，多为短期影响，长期而言随着公司心脑血管业务加速放量，以及近年来在高端医 疗器械研发创新层面的持续投入，蓝帆医疗业务经营或将迈入触底回暖阶段。 据悉，IVL技术是血管内钙化病变治疗中具有突破性价值的技术，由美国Shockwave Med ...

7月15日，建信基金旗下建信北证50成份指数基金开启发售。该基金为被动指数型基金，拟任基金经理 刘明辉。 刘明辉目前在管3只基金（初始基金口径，包括联接及指数基金，下同），其在管总规模超6亿元，包括 建信恒生科技指数等产品。 年费率0.5% 7月11日，建信基金旗下建信北证50成份指数基金发布发售公告。该基金运作方式为契约型开放式，于 2025年7月15日至2025年7月25日公开发售。基金为发起式基金，最低募集份额总额为1000万份，且发起 资金认购的基金份额持有期限不少于3年。 基金投资标的为北证50成份指数。北证50成份指数由北交所规模大、流动性好的最具市场代表性的50只 上市公司证券组成，以综合反映市场整体表现。 | 证券代码 | 证券名称 | 中证一级行业分类 | 中证二级行业分类 | 权重(%) | | --- | --- | --- | --- | --- | | 832982 | 锦波生物 | 医药卫生 | 医疗 | 9.57 | | 835185 | 贝特瑞 | TYK | 电力设备 | 5.92 | | 832522 | 纳科诺尔 | Th | 机械制造 | 3.96 | | 920799 ...

天眼查资料显示，特变电工股份有限公司，成立于1993年，位于昌吉回族自治州，是一家以从事电气机 械和器材制造业为主的企业。企业注册资本505271.0023万人民币。通过天眼查大数据分析，特变电工 股份有限公司共对外投资了55家企业，参与招投标项目5000次，财产线索方面有商标信息361条，专利 信息657条，此外企业还拥有行政许可20个。 西藏开投金上光伏能源有限公司，成立于2022年，位于昌都市，是一家以从事电力、热力生产和供应业 为主的企业。企业注册资本76200万人民币。通过天眼查大数据分析，西藏开投金上光伏能源有限公司 参与招投标项目17次，专利信息6条。 7月15日国家知识产权局信息显示，特变电工股份有限公司;西藏开投金上光伏能源有限公司申请一项名 为"一种光伏电厂升压站的继电保护装置"的专利，公开号CN120320179A，申请日期为2025年05月。 专利摘要显示，本发明公开了一种光伏电厂升压站的继电保护装置，涉及继电保护装置技术领域，包括 外箱，外箱内部安装有继电保护仪，还包括：风机，风机连通在外箱的侧部；过滤机构，过滤机构包括 固定连接在外箱侧部的侧箱，侧箱与风机的输入端连通，侧箱的内部滑 ...

Core Points - In June, the industrial added value above designated size grew by 6.8% year-on-year, accelerating by 1.0 percentage points compared to January-May. For the first half of the year, the growth rate was 6.4% [1] - The strong support for the 6.4% growth rate comes from advanced manufacturing and high-tech industries, particularly high-end equipment manufacturing, which significantly supports the overall industrial economy [1] - Emerging industries such as humanoid robots and 3D printing equipment are expected to see industrialization in the coming years, providing new growth points for the domestic economy [1] Industry Analysis - In June, 36 out of 41 major industries maintained year-on-year growth in added value, with notable increases in various sectors: non-ferrous metal smelting and rolling processing grew by 9.2%, general equipment manufacturing by 7.8%, specialized equipment manufacturing by 4.6%, automotive manufacturing by 11.4%, and electrical machinery and equipment manufacturing by 11.4% [2] - The mining industry saw a year-on-year increase of 6.1%, manufacturing increased by 7.4%, and the electricity, heat, gas, and water production and supply industry grew by 1.8% [1] Future Outlook - Analysts predict that industrial production momentum may weaken in the second half of the year due to factors such as declining exports. It is expected that the annual growth rate of industrial added value will be around 4.8%, primarily impacted by the decline in export growth [4] - The share of export delivery value in China's industrial output is close to 40%, indicating that industrial production growth may experience a sustained slowdown, with a shift in economic growth momentum towards the service sector [4] - Two factors are expected to influence industrial production growth in the second half: the expansion of "anti-involution" efforts leading to sustained production limits in sectors like crude steel and photovoltaics, and a potential decline in export growth following previous "export rush" activities [5]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company is expected to see a significant increase in revenue and net profit, with a forecasted total revenue of 9,258 million yuan in 2025, representing a year-on-year growth of 29.86% [1] - The company's net profit attributable to shareholders is projected to reach 450.54 million yuan in 2025, reflecting a year-on-year increase of 77.41% [1] - The report highlights a strong performance in Q2 2025, with net profit expected to be between 112 to 139 million yuan, indicating a year-on-year growth of 42% to 76% [7] - The company's core business is showing stable growth, with structural components expected to generate over 25 billion yuan in revenue in the first half of 2025, a growth of over 40% year-on-year [7] - The report emphasizes the ongoing development of the company's robotics business, which is expected to contribute significantly to future profits [7] Financial Summary - Total revenue projections for the company are as follows: 6,019 million yuan in 2023, 7,129 million yuan in 2024, 9,258 million yuan in 2025, 11,516 million yuan in 2026, and 14,062 million yuan in 2027 [1] - The company's net profit is forecasted to be 42.77 million yuan in 2023, 253.95 million yuan in 2024, 450.54 million yuan in 2025, 589.48 million yuan in 2026, and 794.03 million yuan in 2027 [1] - The report provides a detailed financial outlook, including earnings per share (EPS) estimates of 0.25 yuan in 2023, 1.46 yuan in 2024, 2.60 yuan in 2025, 3.40 yuan in 2026, and 4.58 yuan in 2027 [1] - The price-to-earnings (P/E) ratio is projected to decrease from 402.37 in 2023 to 21.67 in 2027, indicating improved valuation as earnings grow [1]

自2015年在深圳市成立以来，北芯生命始终对标国际一流的创新产品，经过近十年的研发创新，自主研 发、生产了一系列智能化心血管精准介入解决方案，其中，核心产品血管内超声（IVUS）系统为中国 首个获批的自主创新60MHz高清高速国产IVUS产品和首个在海外获批上市（欧盟MDR）的国产IVUS产 品；核心产品血流储备分数（FFR）系统为金标准FFR领域内中国首个获批的国产产品和首个在海外获 批上市（欧盟MDR）的国产FFR产品，填补了领域内的国产空白，打破了海外巨头在冠脉生理学、影 像学等领域的长期垄断局面。截至目前，公司已在境内外取得20余张三类医疗器械注册证，实现11款产 品的上市销售。 与此同时，公司发挥创新主体地位，推动产业整体向创新驱动发展，实现核心工艺国产化和关键技术突 破。目前，公司是国内唯一掌握60MHz高频微型超声换能器开发与加工制造技术并实现产业化生产的 企业，也是国内唯一掌握完整的微型MEMS压力传感器模块设计与封装技术的企业，在行业内处于领先 地位，公司成功打造了"高性能信号与图像算法及应用软件平台"以持续推动智能化、便捷化，核心产品 IVUS系统是目前行业独家同时具备领先的IVUS全序列 ...

Investment Rating - The report maintains an "Overweight" rating for the machinery industry, indicating a positive outlook compared to the overall market performance [4]. Core Insights - The machinery industry is expected to see a moderate recovery in demand in the second half of 2025, driven by equipment upgrades and technological empowerment [4]. - Key companies in the machinery sector are projected to experience varied growth rates in Q2 2025, with notable performances from companies like SANY Heavy Industry (25% growth) and PCB manufacturer Ding Tai Gao Ke (66% growth) [4][5]. - The report highlights three main trends in the robotics sector: the advancement of humanoid robots, the entry of global giants into the robotics field, and the practical application of various robot forms in specific scenarios [4]. - In the rail transit equipment sector, significant investment is expected to continue, with a projected fixed asset investment nearing 900 billion yuan for the year, supported by strong passenger demand [4]. - The engineering machinery sector is approaching a cyclical turning point, with signs of recovery in demand and a favorable environment for new machine sales [4]. - The laser segment is experiencing rapid growth, particularly in general laser applications, driven by technological advancements and increased overseas exports [4]. Summary by Sections Robotics and Components - The humanoid robot industry is progressing towards commercialization, with significant contributions expected from companies like Greentech Harmonic and Wolong Electric Drive [4]. Rail Transit Equipment - In the first half of 2025, China's railway fixed asset investment reached 355.9 billion yuan, a year-on-year increase of 5.5%, with expectations for continued high growth [4]. Engineering Machinery - The engineering machinery sector has seen improved profitability and is positioned for a new sales cycle as construction activity resumes [4]. Laser Technology - General laser demand is rapidly increasing due to high-power technology iterations and new applications in consumer electronics and photovoltaics [4].

LotosPFA系统能够显著简化手术操作，提升手术效率，同时为临床医生带来极致的操作体验。系统配 套的LotosPFA导管具有针对PFA技术高度定制化创新设计的独特高密度16个电极和高稳定性的耦合式网 篮设计，其可通过变化形态适应更多肺静脉形态，且在所有目标肺静脉位置均不易出现电极变形。此 前，该导管已在动物实验中证实能够实现非旋转消融术式(single-shot)，相关研究成果于2024年初发表 在国际知名的心脏电生理学期刊《EP Europace》上。 近日，2025年欧洲心脏病学会大会(ESC Congress2025)正式公布突破性临床研究专场(Late-Breaking Clinical Trials)入选名单。值得关注的是，由深圳北芯生命科技股份有限公司(以下简称"北芯")旗下控股 子公司——深圳北芯医疗科技有限公司(以下简称"北芯医疗")自主研发的LotosPFA纳秒脉冲电场消融 (nsPFA)系统支持的全球首个nsPFA对比压力感应射频消融(RFA)的InsightPFA前瞻性、多中心、随机对 照研究(RCT)成功入选此名单，相关研究结果将于9月1日在ESC大会进行全球首次发布。 该研究由广东 ...

Group 1 - CITIC Construction Investment expects a net profit of 4.43 billion to 4.57 billion yuan for the first half of 2025, representing a year-on-year increase of 55%-60% [1] - New Hope anticipates a net profit of 680 million to 780 million yuan for the first half of 2025, recovering from a loss of 1.217 billion yuan in the same period last year [2] - Foton Motor forecasts a net profit of approximately 777 million yuan for the first half of 2025, marking an increase of about 87.5% year-on-year [7] Group 2 - North New Road and Bridge expects a net loss of 70 million to 85 million yuan for the first half of 2025 [2] - Nanwei Co. anticipates a net loss of 12 million to 16 million yuan for the first half of 2025 [3] - Hanhua Technology projects a net loss of 45 million to 60 million yuan for the first half of 2025, widening the loss by 11.42%-18.10% compared to the previous year [6] Group 3 - Songlin Technology expects a net profit of 90 million to 95 million yuan for the first half of 2025, a decrease of 57.06%-59.32% year-on-year [4] - Fuchun Environmental Protection anticipates a net profit of 178 million to 207 million yuan for the first half of 2025, representing a year-on-year increase of 80%-110% [18] - Ansteel Group forecasts a net loss of 1.144 billion yuan for the first half of 2025, a reduction in loss of approximately 57.46% compared to the previous year [20][22] Group 4 - China Wuyi expects a net loss of 80 million to 104 million yuan for the first half of 2025, a significant decline compared to the previous year [28] - Meikailong anticipates a net loss of 1.59 billion to 1.92 billion yuan for the first half of 2025 [26] - Aijian Group projects a net profit of 140 million yuan for the first half of 2025, a decrease of 33.26% year-on-year [27]